RBM10 and lung adenocarcinoma: Finally, the PCR results of RBM10 in cancer tissues and adjacent tissues of 20 clinical patients with lung adenocarcinoma were further compared for verification, supporting the conclusion that RBM10 has a negative regulatory effect on the survival and prognosis of lung adenocarcinoma (Figure 9d,e).